Position in NTLA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,887,641
-$2,708,404 QoQ
Shares Held
147,242
-71.2% QoQ
Ownership
0.105%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTLA Over Time
Shares Held
Position Value (USD)
Derivatives in NTLA
reported options exposure · as of Jun 30, 2024CallValue
$1,016,052
CallShares
45,400
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026BARCLAYS PLC holds $1,494,072,071 across 362 Biotechnology names. NTLA ranks #69 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
663,263 | $296,173,457 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
313,093 | $241,908,173 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
220,623 | $72,997,531 | |
| 4 | MRNA |
Moderna, Inc.
|
932,269 | $47,359,264 | |
| 5 | INSM |
INSMED Inc
|
275,731 | $45,087,531 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
1,415,848 | $39,218,988 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
383,179 | $37,264,156 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
669,601 | $35,301,364 |
All Filings in NTLA
Export CSV
34 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,887,641 | 147,242 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $4,596,045 | 511,240 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $8,431,662 | 488,226 | Shares | Sole | 2026-03-31 | |
| 2025-06-30 | $4,860,217 | 518,147 | Shares | Sole | 2026-02-27 | |
| 2025-03-31 | $1,707,081 | 240,096 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $3,633,627 | 311,632 | Shares | Defined | 2026-03-19 | |
| 2024-09-30 | $6,016,936 | 292,795 | Shares | Defined | 2026-03-31 | |
| 2024-06-30 | $1,016,052 | 45,400 | Call | Sole | 2026-03-23 | |
| 2024-06-30 | $4,551,487 | 203,373 | Shares | Sole | 2026-03-23 | |
| 2024-03-31 | $1,182,930 | 43,000 | Put | Sole | 2026-03-24 | |
| 2024-03-31 | $2,049,495 | 74,500 | Call | Sole | 2026-03-24 | |
| 2024-03-31 | $5,097,465 | 185,295 | Shares | Sole | 2026-03-24 | |
| 2023-12-31 | $10,712,050 | 351,330 | Shares | Defined | 2026-03-24 | |
| 2023-12-31 | $1,311,070 | 43,000 | Call | Sole | 2026-03-24 | |
| 2023-12-31 | $2,201,378 | 72,200 | Put | Sole | 2026-03-24 | |
| 2023-09-30 | $8,114,513 | 256,626 | Shares | Sole | 2026-03-26 | |
| 2023-06-30 | $9,096,712 | 223,068 | Shares | Sole | 2026-03-27 | |
| 2023-03-31 | $8,410,086 | 225,653 | Shares | Defined | 2026-03-30 | |
| 2022-12-31 | $9,066,759 | 259,867 | Shares | Defined | 2026-03-30 | |
| 2022-09-30 | $10,328,592 | 184,571 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $5,533,039 | 106,898 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $7,327,823 | 100,837 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $16,406,863 | 138,759 | Shares | Sole | 2022-02-23 | |
| 2021-12-31 | $792,208 | 6,700 | Call | Sole | 2022-02-23 | |
| 2021-09-30 | $7,069,705 | 52,700 | Call | Sole | 2021-11-09 | |
| 2021-09-30 | $10,220,216 | 76,185 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $6,535,010 | 40,362 | Shares | Sole | 2021-08-13 | |
| 2021-06-30 | $18,150,111 | 112,100 | Call | Sole | 2021-08-13 | |
| 2021-03-31 | $8,755,820 | 109,100 | Call | Sole | 2021-05-13 | |
| 2021-03-31 | $7,453,040 | 92,867 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $928,389 | 17,066 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $597,572 | 30,059 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $631,376 | 30,037 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $319,973 | 26,163 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||